US2018243420A1
|
|
Pharmaceutical formulations containing corticosteroids for topical administration
|
CN105848719A
|
|
Anti-infective methods, compositions, and devices
|
CN105683184A
|
|
Stabilized efinaconazole compositions
|
US2014271826A1
|
|
Kinetin/zeatin topical formulation
|
WO2012142145A1
|
|
Methods of treating skin conditions exhibiting telangiectasia
|
EP2643002A1
|
|
Pharmaceutical formulations containing corticosteroids for topical administration
|
US8039494B1
|
|
Compositions and methods for treating diseases of the nail
|
BR112012009644A2
|
|
method for moistening a benzoyl peroxide containing powder
|
CA2738863A1
|
|
Method for obtaining a stable dispersion of benzoyl peroxide
|
BRPI0113247E2
|
|
composition and method for the treatment of skin disorders in a human
|
CA2708203A1
|
|
Imiquimod formulation
|
AU2008343795A1
|
|
Compositions and methods for treating diseases of the nail
|
AU2008295579A1
|
|
Controlled release azithromycin solid dosages forms
|
WO2009020518A1
|
|
Topical acne vulgaris composition with a sunscreen
|
US2009197896A1
|
|
Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
|
WO2008002353A1
|
|
Two-phase mucoadhesive composition
|
WO2007106284A2
|
|
Silicone based emulsions for topical drug delivery
|
US2008081790A1
|
|
Azithromycin for the treatment of nodular acne
|
CA2626551A1
|
|
Azithromycin for treatment of granulomatous rosacea
|
KR20080047312A
|
|
Use of a clobetasol spray formulation to treatment psoriasis
|